Paper32028640
Polyurea Dendrimer Folate-Targeted Nanodelivery of l-Buthionine sulfoximine as a Tool to Tackle Ovarian Cancer Chemoresistance.
Cruz A and 8 others. Antioxidants (Basel), 2020. Cited by 37 papers, by iCite.
Cite this record
ConductScience Library. Polyurea Dendrimer Folate-Targeted Nanodelivery of l-Buthionine sulfoximine as a Tool to Tackle Ovarian Cancer Chemoresistance. Papers, record 32028640. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32028640
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Polyurea Dendrimer Folate-Targeted Nanodelivery of l-Buthionine sulfoximine as a Tool to Tackle Ovarian Cancer Chemoresistance.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| PTDC/MEC-ONC/29327/2017 | fundação ciência e tecnologia | PubMed | ||
| UID/Multi/04462 | fundação ciência e tecnologia | PubMed |
Source PubMed
References39
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 26520442 | HNF1β drives glutathione (GSH) synthesis underlying intrinsic carboplatin resistance of ovarian clear cell carcinoma (OCCC). | Tumour Biol | 2016 | https://conductscience.org/library/papers/26520442 | PubMed |
| 2 | 24767708 | Ovarian cancer. | Lancet | 2014 | https://conductscience.org/library/papers/24767708 | PubMed |
| 3 | 25967350 | POxylated Polyurea Dendrimers: Smart Core-Shell Vectors with IC50 Lowering Capacity. | Macromol Biosci | 2015 | https://conductscience.org/library/papers/25967350 | PubMed |
| 4 | 29949936 | Glutathione in Ovarian Cancer: A Double-Edged Sword. | Int J Mol Sci | 2018 | https://conductscience.org/library/papers/29949936 | PubMed |
| 5 | 29992403 | Preparation of Folic Acid-Targeted Temperature-Sensitive Magnetoliposomes and their Antitumor Effects In Vitro and In Vivo. | Target Oncol | 2018 | https://conductscience.org/library/papers/29992403 | PubMed |
| 6 | 31635026 | Targeting Glutathione and Cystathionine β-Synthase in Ovarian Cancer Treatment by Selenium-Chrysin Polyurea Dendrimer Nanoformulation. | Nutrients | 2019 | https://conductscience.org/library/papers/31635026 | PubMed |
| 7 | 8097674 | Glutathione depletion by L-buthionine sulfoximine antagonizes taxol cytotoxicity. | Cancer Res | 1993 | https://conductscience.org/library/papers/8097674 | PubMed |
| 8 | 1348364 | High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis. | Proc Natl Acad Sci U S A | 1992 | https://conductscience.org/library/papers/1348364 | PubMed |
| 9 | 29921232 | Cysteine boosters the evolutionary adaptation to CoCl2 mimicked hypoxia conditions, favouring carboplatin resistance in ovarian cancer. | BMC Evol Biol | 2018 | https://conductscience.org/library/papers/29921232 | PubMed |
| 10 | 17991446 | Mechanisms of BSO (L-buthionine-S,R-sulfoximine)-induced cytotoxic effects in neuroblastoma. | Free Radic Biol Med | 2008 | https://conductscience.org/library/papers/17991446 | PubMed |
| 11 | 30546448 | Oxidative stress induced by carboplatin promotes apoptosis and inhibits migration of HN-3 cells. | Oncol Lett | 2018 | https://conductscience.org/library/papers/30546448 | PubMed |
| 12 | 8420689 | Mechanisms of drug resistance in ovarian cancer. | Cancer | 1993 | https://conductscience.org/library/papers/8420689 | PubMed |
| 13 | 19061505 | Buthionine sulfoximine sensitizes antihormone-resistant human breast cancer cells to estrogen-induced apoptosis. | Breast Cancer Res | 2008 | https://conductscience.org/library/papers/19061505 | PubMed |
| 14 | 14576837 | Cisplatin: mode of cytotoxic action and molecular basis of resistance. | Oncogene | 2003 | https://conductscience.org/library/papers/14576837 | PubMed |
| 15 | 20220146 | Structural basis for feedback and pharmacological inhibition of Saccharomyces cerevisiae glutamate cysteine ligase. | J Biol Chem | 2010 | https://conductscience.org/library/papers/20220146 | PubMed |
| 16 | 22474030 | Involvement of intracellular glutathione in regulating isoline-induced cytotoxicity in human normal liver L-02 cells. | Toxicol Ind Health | 2013 | https://conductscience.org/library/papers/22474030 | PubMed |
| 17 | 12217624 | Glutathione depletion and oxidative stress. | Parkinsonism Relat Disord | 2002 | https://conductscience.org/library/papers/12217624 | PubMed |
| 18 | 22025878 | Preclinical evaluation of azathioprine plus buthionine sulfoximine in the treatment of human hepatocarcinoma and colon carcinoma. | World J Gastroenterol | 2011 | https://conductscience.org/library/papers/22025878 | PubMed |
| 19 | 28008141 | Chemoresistance and targeted therapies in ovarian and endometrial cancers. | Oncotarget | 2017 | https://conductscience.org/library/papers/28008141 | PubMed |
| 20 | 31461931 | l-Buthionine Sulfoximine Detection and Quantification in Polyurea Dendrimer Nanoformulations. | Molecules | 2019 | https://conductscience.org/library/papers/31461931 | PubMed |
Cited by20
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 37 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42435186 | Lipid Remodeling and Metabolic Adaptation in Cancer Cell Membranes: A Platform for Membrane-Targeted Nanotherapy. | Adv Exp Med Biol | 2026 | https://conductscience.org/library/papers/42435186 | PubMed |
| 41838426 | Targeting TNBC: core-shell polycationic polyurea dendrimers with inherent anticancer activity. | FEBS Open Bio | 2026 | https://conductscience.org/library/papers/41838426 | PubMed |
| 41627590 | Glutathione responsive nanomedicine leverages tumor redox imbalance for targeted cancer theranostics. | Discov Oncol | 2026 | https://conductscience.org/library/papers/41627590 | PubMed |
| 41558606 | Metabolic vulnerabilities in ovarian cancer decoding the nexus between nutrient adaptation and therapy resistance. | J Adv Res | 2026 | https://conductscience.org/library/papers/41558606 | PubMed |
| 41497304 | Overview of dendrimers as promising drug delivery systems with insight into anticancer and anti-microbial applications. | Int J Pharm X | 2025 | https://conductscience.org/library/papers/41497304 | PubMed |
| 41376855 | Platinum-resistant ovarian cancer: From mechanisms to treatment strategies. | Genes Dis | 2026 | https://conductscience.org/library/papers/41376855 | PubMed |
| 40872553 | Chrysin: A Comprehensive Review of Its Pharmacological Properties and Therapeutic Potential. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/40872553 | PubMed |
| 40749079 | Machine learning combining external validation to explore the immunopathogenesis of diabetic foot ulcer and predict therapeutic drugs. | PLoS One | 2025 | https://conductscience.org/library/papers/40749079 | PubMed |
| 40289180 | Lactate-coated polyurea-siRNA dendriplex: a gene therapy-directed and metabolism-based strategy to impair glioblastoma (GBM). | Cancer Gene Ther | 2025 | https://conductscience.org/library/papers/40289180 | PubMed |
| 40155504 | Nanotechnology-based drug delivery system for the diagnosis and treatment of ovarian cancer. | Discov Oncol | 2025 | https://conductscience.org/library/papers/40155504 | PubMed |
| 39034325 | Host cell CRISPR genomics and modelling reveal shared metabolic vulnerabilities in the intracellular development of Plasmodium falciparum and related hemoparasites. | Nat Commun | 2024 | https://conductscience.org/library/papers/39034325 | PubMed |
| 38966382 | Maleimide functionalized polycaprolactone micelles for glutathione quenching and doxorubicin delivery. | Chem Sci | 2024 | https://conductscience.org/library/papers/38966382 | PubMed |
| 38853202 | Targeting PAX8 sensitizes ovarian cancer cells to ferroptosis by inhibiting glutathione synthesis. | Apoptosis | 2024 | https://conductscience.org/library/papers/38853202 | PubMed |
| 38500284 | The Application of Nanotechnological Therapeutic Platforms against Gynecological Cancers. | Curr Pharm Des | 2024 | https://conductscience.org/library/papers/38500284 | PubMed |
| 38247476 | H2S-Synthesizing Enzymes Are Putative Determinants in Lung Cancer Management toward Personalized Medicine. | Antioxidants (Basel) | 2023 | https://conductscience.org/library/papers/38247476 | PubMed |
| 37564206 | Unraveling the Complexity of Regulated Cell Death in Esophageal Cancer: from Underlying Mechanisms to Targeted Therapeutics. | Int J Biol Sci | 2023 | https://conductscience.org/library/papers/37564206 | PubMed |
| 36259505 | Nanotechnological approaches for diagnosis and treatment of ovarian cancer: a review of recent trends. | Drug Deliv | 2022 | https://conductscience.org/library/papers/36259505 | PubMed |
| 35585292 | Current Update on Nanotechnology-Based Approaches in Ovarian Cancer Therapy. | Reprod Sci | 2023 | https://conductscience.org/library/papers/35585292 | PubMed |
| 34984953 | Amplification of anticancer efficacy by co-delivery of doxorubicin and lonidamine with extracellular vesicles. | Drug Deliv | 2022 | https://conductscience.org/library/papers/34984953 | PubMed |
| 34924003 | Antioxidant supplements promote tumor formation and growth and confer drug resistance in hepatocellular carcinoma by reducing intracellular ROS and induction of TMBIM1. | Cell Biosci | 2021 | https://conductscience.org/library/papers/34924003 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| FANCB | 2187 | PubTator's text mining | https://conductscience.org/library/genes/2187 | NCBI Gene |
| FOLR1 | 2348 | PubTator's text mining | https://conductscience.org/library/genes/2348 | NCBI Gene |
| GCLC | 2729 | PubTator's text mining | https://conductscience.org/library/genes/2729 | NCBI Gene |
| GCLM | 2730 | PubTator's text mining | https://conductscience.org/library/genes/2730 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32028640
GET https://conductscience.org/api/papers/v1/32028640/references?page=2